{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:25:21Z","timestamp":1789424721183,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11894-020-0756-8","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T13:02:47Z","timestamp":1584450167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Refractory Celiac Disease"],"prefix":"10.1007","volume":"22","author":[{"given":"Isabel A.","family":"Hujoel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"12","key":"756_CR1","first-page":"A5307","volume":"63","author":"S Rowinski","year":"2016","unstructured":"Rowinski S, Christensen E. Epidemiologic and therapeutic aspects of refractory coeliac disease - a systematic review. Dan Med J. 2016;63(12):A5307.","journal-title":"Dan Med J"},{"issue":"2","key":"756_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/apt.13867","volume":"45","author":"W Eigner","year":"2017","unstructured":"Eigner W, Bashir K, Primas C, Kazemi-Shirazi L, Wrba F, Trauner M, et al. Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years. Aliment Pharmacol Ther. 2017;45(2):364\u201372.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"756_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0016-5085(03)00692-9","volume":"125","author":"V Verkarre","year":"2003","unstructured":"Verkarre V, Romana S, Cellier C, Asnafi V, Mention J, Barbe U, et al. Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology. 2003;125(1):40\u20136.","journal-title":"Gastroenterology."},{"issue":"3","key":"756_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/gut.30.3.333","volume":"30","author":"G Holmes","year":"1989","unstructured":"Holmes G, Prior P, Lane M, Pope D, Allan R. Malignancy in coeliac disease --effect of a gluten free diet. Gut. 1989;30(3):333\u20138.","journal-title":"Gut."},{"issue":"1","key":"756_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","volume":"136","author":"G Malamut","year":"2009","unstructured":"Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, Damotte D, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136(1):81\u201390.","journal-title":"Gastroenterology."},{"issue":"8","key":"756_CR6","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.cgh.2016.03.022","volume":"14","author":"V Perfetti","year":"2016","unstructured":"Perfetti V, Baldanti F, Lenti M, Vanoli A, Biagi F, Gatti M, et al. Detection of active Epstein-Barr virus infection in duodenal mucosa of patients with refractory celiac disease. Clin Gastroenterol Hepatol. 2016;14(8):1216\u201320.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"756_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cgh.2005.12.011","volume":"4","author":"A Al-Toma","year":"2006","unstructured":"Al-Toma A, Goerres M, Meijer J, Pena A, Crusius J, Mulder C. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol. 2006;4(3):315\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"756_CR8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.cgh.2007.08.018","volume":"5","author":"V Wolters","year":"2007","unstructured":"Wolters V, Verbeek W, Zhernakova A, Onland-Moret C, Schreuers M, Monsuur A, et al. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin Gastroenterol Hepatol. 2007;5(12):1399\u2013405.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"756_CR9","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/MEG.0000000000001168","volume":"30","author":"B Hrdlickova","year":"2018","unstructured":"Hrdlickova B, Mulder C, Malamut G, Meresse B, Platteel M, Kamatani Y, et al. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease. Eur J Gastroenterol Hepatol. 2018;30(8):828\u201337.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"756_CR10","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/gutjnl-2018-317371","volume":"68","author":"M Cheminant","year":"2019","unstructured":"Cheminant M, Bruneau J, Malamut G, Sibon D, Guegan N, van Gils T, et al. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study. Gut. 2019;68(8):1396\u2013405.","journal-title":"Gut."},{"issue":"3","key":"756_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","volume":"45","author":"J Ettersperger","year":"2016","unstructured":"\u2022\u2022 Ettersperger J, Montcuquet N, Malamut G, Guegan N, Lopez-Lastra S, Gayraud S, et al. Interleukin-15-dependent T-Cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease. Immunity. 2016;45(3):610\u201325 Detailed review of the role of IL-15 in celiac disease.","journal-title":"Immunity"},{"issue":"2","key":"756_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/ajg.2013.426","volume":"109","author":"A Di Sabatino","year":"2014","unstructured":"Di Sabatino A, Giuffrida P, Vanoli A, Luinetti O, Manca R, Biancheri P, et al. Increase in neuroendocrine cells in the duodenal mucosa of patients with refractory celiac disease. Am J Gastroenterol. 2014;109(2):258\u201369.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"756_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","volume":"125","author":"J Mention","year":"2003","unstructured":"Mention J, Ben Ahmed M, Begue B, Barbe U, Verkarre V, Asnafi V, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology. 2003;125(3):730\u201345.","journal-title":"Gastroenterology."},{"issue":"3","key":"756_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/imm.12690","volume":"150","author":"S Sedda","year":"2017","unstructured":"Sedda S, De Simone V, Marafini I, Bevivino G, Izzo R, Paoluzi O, et al. High Smad7 sustains inflammatory cytokine response in refractory coeliac disease. Immunology. 2017;150(3):356\u201363.","journal-title":"Immunology."},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11899-018-0459-5","volume":"13","author":"U Chander","year":"2018","unstructured":"Chander U, Leeman-Neill RJ, Bhagat G. Pathogenesis of Enteropathy-Associated T Cell Lymphoma. Current Hematologic Malignancy Reports. 2018;13:308\u201317.","journal-title":"Current Hematologic Malignancy Reports"},{"issue":"1","key":"756_CR16","doi-asserted-by":"publisher","first-page":"e000026","DOI":"10.1136\/bmjgast-2014-000026","volume":"2","author":"R van Wanrooij","year":"2015","unstructured":"van Wanrooij R, de Jong D, Langerak A, Yistra B, van Essen H, Heideman D, et al. Novel variant of EATL evolving from mucosal \u03b3\u03b4-T-cells in a patient with type I RCD. BMJ Open Gastroenterol. 2015;2(1):e000026.","journal-title":"BMJ Open Gastroenterol"},{"issue":"3","key":"756_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.clnu.2015.04.014","volume":"35","author":"N Wierdsma","year":"2016","unstructured":"Wierdsma N, Nijeboer P, de van der Schueren M, Berkenpas M, van Bodegraven A, Mulder C. Refractory celiac disease and EATL patients show severe malnutrition and malabsorption at diagnosis. Clin Nutr. 2016;35(3):685\u201391.","journal-title":"Clin Nutr"},{"issue":"1","key":"756_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.15403\/jgld.2014.1121.281.cel","volume":"28","author":"S Chetcuti Zammit","year":"2019","unstructured":"\u2022 Chetcuti Zammit S, Sanders D, Cross S, Sidhu R. Capsule endoscopy in the management of refractory coeliac disease. J Gastrointestin liver dis. 2019;28(1):15\u201322 Study investigating the role of a second capsule endoscopy in the management of refractory celiac disease.","journal-title":"J Gastrointestin liver dis"},{"key":"756_CR19","doi-asserted-by":"crossref","unstructured":"Giuffrida P, Aronico N, Rosselli M, Lenti M, Cococcia S, Roccarina D, et al. Defective spleen function in autoimmune gastrointestinal disorders. Intern Emerg Med. 2019.","DOI":"10.1007\/s11739-019-02129-w"},{"issue":"4","key":"756_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/gut.2009.195131","volume":"59","author":"A Rubio-Tapia","year":"2010","unstructured":"Rubio-Tapia A, Murray J. Classification and management of refractory celiac disease. Gut. 2010;59(4):547\u201357.","journal-title":"Gut."},{"issue":"5","key":"756_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","volume":"7","author":"A Al-Toma","year":"2019","unstructured":"Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders D, Cellier C, et al. European Society for the study of coeliac disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019;7(5):583\u2013613.","journal-title":"United European Gastroenterol J"},{"issue":"8","key":"756_CR22","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1111\/j.1572-0241.2002.05917.x","volume":"97","author":"A Abdulkarim","year":"2002","unstructured":"Abdulkarim A, Burgart L, See J, Murray J. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol. 2002;97(8):2016\u201321.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"756_CR23","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/ajg.2016.439","volume":"111","author":"I Comino","year":"2016","unstructured":"Comino I, Fernandez-Banares F, Esteve M, Ortigosa L, Castillejo G, Fambuena B, et al. Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients. Am J Gastroenterol. 2016;111(10):1456\u201365.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"756_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/gutjnl-2015-310148","volume":"66","author":"M Moreno","year":"2017","unstructured":"Moreno M, Cebolla A, Munoz-Suano A, Carrillo-Carrion C, Comino I, Pizarro A, et al. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut. 2017;66(2):250\u20137.","journal-title":"Gut."},{"issue":"1","key":"756_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","volume":"126","author":"W Verbeek","year":"2008","unstructured":"Verbeek W, Goerres M, Von Blomberg B, Oudejans J, Scholten P, Scholten P, et al. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease. Clin Immunol. 2008;126(1):48\u201356.","journal-title":"Clin Immunol"},{"issue":"2","key":"756_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gut.52.2.205","volume":"52","author":"V Verkarre","year":"2003","unstructured":"Verkarre V, Asnafi V, Lecomte T, Patey Mariaud-De Serre N, Leborgne M, Grosdidier E, et al. Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut. 2003;52(2):205\u201311.","journal-title":"Gut."},{"issue":"23","key":"756_CR27","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1182\/blood-2014-04-566513","volume":"123","author":"J Pastre","year":"2014","unstructured":"Pastre J, Juvin K, Malamut G, Derrieux C, Cellier C, Israel-Biet D. Phenotypically aberrant clonal T cells in the lungs of patients with type II refractory celiac disease. Blood. 2014;123(23):3674\u20135.","journal-title":"Blood."},{"issue":"1","key":"756_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jmoldx.2018.08.006","volume":"21","author":"C Derrieux","year":"2019","unstructured":"Derrieux C, Trinquand A, Bruneau J, Verkarre V, Lhermitte L, Alcantara M, et al. A single-tube, EuroClonality-inspired, TRG clonality multiplex PCR aids management of patients with enteropathic diseases, including from formaldehyde-fixed. Paraffin-Embedded Tissues J Mol Diagn. 2019;21(1):111\u201322.","journal-title":"Paraffin-Embedded Tissues J Mol Diagn"},{"issue":"2","key":"756_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/PAS.0000000000001172","volume":"43","author":"R Celli","year":"2019","unstructured":"Celli R, Hui P, Triscott H, Bogardus S, Gibson J, Hwang M, et al. Clinical insignificance of monoclonal T-cell populations and duodenal intraepithelial T-cell phenotypes in celiac and nonceliac patients. Am J Surg Pathol. 2019;43(2):151\u201360.","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"756_CR30","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jclinpath-2018-205023","volume":"71","author":"S Hussein","year":"2018","unstructured":"\u2022\u2022 Hussein S, Gindin T, Lagana S, Arguelles-Grande C, Krishnareddy S, Alobeid B, et al. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease. J Clin Pathol. 2018;71(9):825\u201331 Study demonstrating the potential pitfalls in relying on T-cell receptor gene rearrangements for diagnosing refractory celiac disease.","journal-title":"J Clin Pathol"},{"issue":"7","key":"756_CR31","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s10875-014-0075-7","volume":"34","author":"R van Wanrooij","year":"2014","unstructured":"van Wanrooij R, Muller D, Neefjes-Borst E, Meijer J, Koudstaal L, Heideman D, et al. Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease. J Clin Immunol. 2014;34(7):828\u201335.","journal-title":"J Clin Immunol"},{"key":"756_CR32","unstructured":"Rouvroye M, Wicaksono A, Bosch S, Savelkoul E, Covington J, Beaumont H, et al. Faecal scent as a novel Nnn-invasive biomarker to discriminate between coeliac disease and refractory coeliac disease: a proof of principle study. Biosensors. 2019;(2):9, E69."},{"key":"756_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.dld.2016.02.015","volume":"48","author":"F Branchi","year":"2016","unstructured":"Branchi F, Locatelli M, Tomba C, Conte D, Ferretti F, Elli L. Enteroscopy and radiology for the management of celiac disease complications: time for a pragmatic roadmap. Dig Liver Dis. 2016;48:578\u201386.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"756_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.gie.2017.04.006","volume":"86","author":"L Elli","year":"2017","unstructured":"Elli L, Casazza G, Locatelli M, Branchi F, Ferretti F, Conte D, et al. Use of enteroscopy for the detection of malignant and premalignant lesions of the small bowel in complicated celiac disease: a meta-analysis. Gastrointest Endosc. 2017;86(2):264\u201373.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"756_CR35","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/jmri.25646","volume":"46","author":"A Radmard","year":"2017","unstructured":"Radmard A, Hashemi Taheri A, Salehian Nik E, Kooraki S, Kolahdoozan S, Mirminachi B, et al. MR enterography in nonresponsive adult celiac disease: correlation with endoscopic, pathologic, serologic, and genetic features. J Magn Reson Imaging. 2017;46(4):1096\u2013106.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"756_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00261-016-1032-0","volume":"42","author":"B Al-Bawardy","year":"2017","unstructured":"\u2022 Al-Bawardy B, Barlow J, Vasconcelos R, Kim S, Bruining D, Hansel S, et al. Cross-sectional imaging in refractory celiac disease. Abdom Radiol. 2017;42(2):389\u201395 Study illustrating radiographic differences between type II, type I refractory celiac disease, and healed celiac disease.","journal-title":"Abdom Radiol"},{"issue":"3","key":"756_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/2050640616663571","volume":"5","author":"T van Gils","year":"2017","unstructured":"van Gils T, Nijeboer P, van Waesberghe J, Coupe V, Janssen K, Zegers J, et al. Splenic volume differentiates complicated and non-complicated celiac disease. United European Gastroenterol J. 2017;5(3):374\u20139.","journal-title":"United European Gastroenterol J"},{"issue":"6","key":"756_CR38","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ajg.2017.71","volume":"112","author":"S Mukewar","year":"2017","unstructured":"\u2022\u2022 Mukewar S, Sharma A, Rubio-Tapia A, Wu T, Jabri B, Murray J. Open-capsule budesonide for refractory celiac disease. Am J Gastroenterol. 2017;112(6):959\u201367 Study investigating the role of budesonide in type I and type II refractory celiac disease management.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"756_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/gut.2006.114512","volume":"56","author":"A Al-Toma","year":"2007","unstructured":"Al-Toma A, Verbeek W, Hadithi M, Von Blomberg B, Mulder C. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56(10):1373\u20138.","journal-title":"Gut."},{"issue":"2","key":"756_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.14309\/crj.2015.25","volume":"2","author":"N Rawal","year":"2015","unstructured":"Rawal N, Twaddell W, Fasano A, Blanchard S, Safta A. Remission of refractory celiac disease with infliximab in a pediatric patient. ACG Case Rep J. 2015;2(2):121\u20133.","journal-title":"ACG Case Rep J"},{"issue":"11","key":"756_CR41","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","volume":"4","author":"A Al-Toma","year":"2006","unstructured":"\u2022\u2022 Al-Toma A, Goerres M, Meijer J, von Blomberg B, Wahab P, Kerckhaert J, et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol. 2006;4(11):1322\u20137 Recently published guidelines on celiac disease that include a detailed discussion of refractory celiac disease.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"756_CR42","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/gut.2005.089987","volume":"55","author":"X Dray","year":"2006","unstructured":"Dray X, Joly F. Lavergne-Slove a, Treton X, Bouhnik Y, messing B. a severe but reversible refractory sprue. Gut. 2006;55(8):1210\u20131.","journal-title":"Gut."},{"key":"756_CR43","doi-asserted-by":"crossref","unstructured":"Maheshwari P, Feeley I, Oleary H, Goulding C. A 37-year-old woman with refractory coeliac disease type II disease treated by stem cell transplantation. BMJ Case Rep. 2015.","DOI":"10.1136\/bcr-2015-209363"},{"issue":"4","key":"756_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","volume":"17","author":"G Tack","year":"2011","unstructured":"Tack G, Verbeek W, Al-Toma A, Kuik D, Schreurs W, Visser O, et al. Evaluation of cladribine treatment in refractory celiac disease type II. World J Gastroenterol. 2011;17(4):506\u201313.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"756_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/2050640616646529","volume":"5","author":"P Nijeboer","year":"2017","unstructured":"Nijeboer P, Van Wanrooij R, Van Gils T, Wierdsma N, Tack G, Witte B, et al. Lymphoma development and survival in refractory coeliac disease type II: histological response as prognostic factor. United European Gastroenterol J. 2017;5(2):208\u201317.","journal-title":"United European Gastroenterol J"},{"issue":"6","key":"756_CR46","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/bmt.2010.199","volume":"46","author":"G Tack","year":"2011","unstructured":"Tack G, Wondergem M, Al-Toma A, Verbeek W, Schmittel A, Machado M, et al. Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. Bone Marrow Transplant. 2011;46(6):840\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"756_CR47","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.mayocp.2016.03.001","volume":"91","author":"R Ciccocioppo","year":"2016","unstructured":"Ciccocioppo R, Gallia A, Avanzini M, Betti E, Picone C, Vanoli A, et al. A refractory celiac patient successfully treated with mesenchymal stem cell infusions. Mayo Clin Proc. 2016;91(6):812\u20139.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"756_CR48","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/19420862.2017.1332553","volume":"9","author":"A Vicari","year":"2017","unstructured":"Vicari A, Schoepfer A, Meresse B, Goffin L, Leger O, Josserand S, et al. Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis. MAbs. 2017;9(6):927\u201344.","journal-title":"MAbs."},{"issue":"6","key":"756_CR49","doi-asserted-by":"publisher","first-page":"S-129","DOI":"10.1016\/S0016-5085(18)30859-X","volume":"154","author":"C Cellier","year":"2018","unstructured":"Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, et al. 616-AMG 714 (Anti-IL-15 MAB) halts the progression of aberrant intraepithelial lymphocytes in refractory celiac disease type II (RCD-II): a Phase 2A, randomized, double-blind, placebo-controlled study evaluating AMG 714 in adult patients with RCD-II\/Pre-EATL. Gastroenterology. 2018;154(6):S-129\u2013S-30.","journal-title":"Gastroenterology"},{"issue":"3","key":"756_CR50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.15403\/jgld.2014.1121.253.cel","volume":"25","author":"Y van Beurden","year":"2016","unstructured":"van Beurden Y, van Gils T, van Gils N, Kassam Z, Mulder C, Aparicio-Pages N. Serendipity in refractory celiac disease: full recovery of duodenal villi and clinical symptoms after fecal microbiota transfer. J Gastrointestin Liver Dis. 2016;25(3):385\u20138.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"7","key":"756_CR51","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/apt.13755","volume":"44","author":"A Rubio-Tapia","year":"2016","unstructured":"\u2022 Rubio-Tapia A, Malamut G, Verbeek W, van Wanrooij R, Leffler D, Niveloni S, et al. Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry. Aliment Pharmacol Ther. 2016;44(7):704\u201314 Model predicting survival in refractory celiac disease.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-020-0756-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-020-0756-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-020-0756-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:41:20Z","timestamp":1615941680000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-020-0756-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s11894-020-0756-8","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"17 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"<i>Joseph A. Murray<\/i> receives grant support from; Nexpep\/ImmusanT Inc., National Institutes of Health, Immunogenix, Takeda Pharmaceutical Inc., Allakos Inc., Oberkotter Foundation, Cour Inc.; is a consultant to Bionix, Lilly Research Laboratory, Johnson & Johnson, Dr. Schar USA Inc., UCB Biopharma, Innovate Biopharmaceuticals, Glenmark Pharmaceuticals, Celimmune, Amgen Intrexon Corporation, Kanyos, and Boehringer Ingelheim; holds patents licensed to Evelo Biosciences Inc.; and receives royalties from Torax Medical.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding Information"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}],"article-number":"18"}}